Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pseudoephedrine

This article was originally published in The Tan Sheet

Executive Summary

Bill making it unlawful to possess more than 5 g pseudoephedrine passes Arkansas House of Representatives Public Health Committee Feb. 22 after clearing Senate three days earlier. CHPA says it will seek to have legislation returned to committee for full hearing. Trade group notes SB 66, which it opposes, would make it illegal to purchase two, 96-count boxes of pseudoephedrine, each containing 2.88 g. CHPA also testified Feb. 15 against House Bill 1417, which would classify decongestant ingredient as Schedule V substance to be dispensed only under direct pharmacist supervision and limit consumer purchases to one package every 48 hours. HB 1417 has been placed on hold for now, CHPA notes

You may also be interested in...



Pseudoephedrine

Amended bill restricting pseudoephedrine-containing OTC sales to three packages per transaction is before Arkansas Senate Judiciary Committee following House passage March 12. The bill, HB 1417, also would make it illegal to sell such products to anyone under 18. CHPA had opposed an earlier version of the bill, which would have classified pseudoephedrine as a Schedule V substance to be dispensed only under direct pharmacist supervision (1"The Tan Sheet" Feb. 26, In Brief). Similar legislation restricting the quantity of pseudoephedrine that may be purchased in a single transaction is being considered in Missouri (SB 608) and Washington (SB 5017)

Pseudoephedrine

Amended bill restricting pseudoephedrine-containing OTC sales to three packages per transaction is before Arkansas Senate Judiciary Committee following House passage March 12. The bill, HB 1417, also would make it illegal to sell such products to anyone under 18. CHPA had opposed an earlier version of the bill, which would have classified pseudoephedrine as a Schedule V substance to be dispensed only under direct pharmacist supervision (1"The Tan Sheet" Feb. 26, In Brief). Similar legislation restricting the quantity of pseudoephedrine that may be purchased in a single transaction is being considered in Missouri (SB 608) and Washington (SB 5017)

Pseudoephedrine

Amended bill restricting pseudoephedrine-containing OTC sales to three packages per transaction is before Arkansas Senate Judiciary Committee following House passage March 12. The bill, HB 1417, also would make it illegal to sell such products to anyone under 18. CHPA had opposed an earlier version of the bill, which would have classified pseudoephedrine as a Schedule V substance to be dispensed only under direct pharmacist supervision (1"The Tan Sheet" Feb. 26, In Brief). Similar legislation restricting the quantity of pseudoephedrine that may be purchased in a single transaction is being considered in Missouri (SB 608) and Washington (SB 5017)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel